Latigo Biotherapeutics, Inc. Stock

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-01 EDT			5-day change	1st Jan Change
22.26 ^USD	+1.09%		-1.37%	-

09-01	Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target	MT

09-01	Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target	MT
09-01	Guggenheim Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Goldman Sachs Initiates Latigo Biotherapeutics at Buy With $73 Price Target	MT
08-09	Latigo Biotherapeutics, Inc.(NasdaqGS:LTGO) added to NASDAQ Composite Index	CI
08-07	Latigo Biotherapeutics Shares Rise in Nasdaq Debut	MT
08-07	Latigo Biotherapeutics Prices $345.6 Million IPO	MT
08-06	Latigo Biotherapeutics, Inc. has completed an IPO in the amount of $345.6 million.	CI

09-01	Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target	MT
09-01	Guggenheim Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Goldman Sachs Initiates Latigo Biotherapeutics at Buy With $73 Price Target	MT

Manager	Title	Age	Since
Nima Farzan CEO	Chief Executive Officer	50	2024-07-21
Neha Krishnamohan DFI	Director of Finance/CFO	39	2026-01-31
Cynthia Voong CTO	Chief Tech/Sci/R&D Officer	-	2024-07-31

Director	Title	Age	Since
Nima Farzan BRD	Director/Board Member	50	2024-07-21
Timothy Walbert CHM	Chairman	59	2024-09-30
Sara Bonstein BRD	Director/Board Member	45	2026-03-31

Date	Insider	Type	Main position	Quantity	% Market Cap.
8/10/26	Westlake Biopartners LLC	Conversion	Company	25,390,610	40.1509%
8/10/26	5AM Venture Management LLC	Conversion	Company	14,651,924	23.1695%
8/10/26	Foresite Capital Management LLC	Conversion	Company	18,222,656	28.8160%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LATIGO BIOTHERAPEUTICS, INC.	+1.09%	-1.37%	-	-	1.39B
LONZA GROUP AG	+0.21%	-2.69%	+1.19%	+17.32%	49.81B
REVOLUTION MEDICINES, INC.	+2.09%	-0.71%	+452.73%	+498.77%	44.06B
IQVIA HOLDINGS INC.	-1.09%	-0.41%	+35.40%	+15.17%	42.99B
BEONE MEDICINES AG	-0.26%	-4.71%	+17.19%	+71.67%	40.88B
CELLTRION, INC.	-0.48%	-0.84%	+16.25%	+49.80%	33.11B
MEDPACE HOLDINGS, INC.	-1.81%	-5.02%	+22.65%	+113.24%	16.58B
ASCENDIS PHARMA A/S	-1.06%	+2.87%	-	-	17.27B
EUROFINS SCIENTIFIC SE	-1.35%	-3.40%	+10.13%	+26.34%	14.63B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.05%	-5.14%	+72.89%	+34.69%	13.76B
Average	-0.63%	-1.80%	+78.55%	+103.38%	27.45B
Weighted average by Cap.	-0.50%	-1.75%	+94.97%	+120.43%